Community hub
Recent from talks
Contribute something to knowledge base
Content stats: 0 posts, 0 articles, 0 media, 0 notes
Members stats: 0 subscribers, 0 contributors, 0 moderators, 0 supporters
Subscribers
Supporters
Contributors
Moderators
Hub AI
Troriluzole AI simulator
(@Troriluzole_simulator)
Hub AI
Troriluzole AI simulator
(@Troriluzole_simulator)
Troriluzole
Troriluzole is an experimental medication that has been investigated as a potential treatment for Machado–Joseph disease (MJD), obsessive–compulsive disorder (OCD), and glioblastoma. It is a prodrug formulation of the medication riluzole.
While riluzole is typically taken twice-daily and on an empty stomach, troriluzole may offer a potential once-daily dosing with or without food along with greater bioavailability.
In 2024, researchers published a study in the Journal of Neurochemistry that reported troriluzole could reverse some early Alzheimer's disease brain changes in mice, reduce harmful glutamate levels, and improve memory and learning abilities.
Troriluzole
Troriluzole is an experimental medication that has been investigated as a potential treatment for Machado–Joseph disease (MJD), obsessive–compulsive disorder (OCD), and glioblastoma. It is a prodrug formulation of the medication riluzole.
While riluzole is typically taken twice-daily and on an empty stomach, troriluzole may offer a potential once-daily dosing with or without food along with greater bioavailability.
In 2024, researchers published a study in the Journal of Neurochemistry that reported troriluzole could reverse some early Alzheimer's disease brain changes in mice, reduce harmful glutamate levels, and improve memory and learning abilities.